Skip to content

Clinical trials

Dyslipidemias trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: Finland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20052
20065
20092
20131
20141
20151
20161
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kowa Research Europe3
Sanofi3
Amgen2
Solvay Pharmaceuticals2
Amarin Pharma Inc.1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
GlaxoSmithKline1
Marjukka Kolehmainen1
Newcastle University1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias19
Hypercholesterolemia7
Obesity5
Diabetes Mellitus, Type 24
Cardiovascular Diseases3
Hypertension3
Atherosclerosis2
Diabetes Mellitus2
Glucose Metabolism Disorders2
Overweight2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.